Mucolipidosis II and III: different residual activity of beta-galactosidase in cultured fibroblasts
- PMID: 1269176
- DOI: 10.1111/j.1399-0004.1976.tb01608.x
Mucolipidosis II and III: different residual activity of beta-galactosidase in cultured fibroblasts
Abstract
A biochemical difference is found between the mucolipidoses II and III which may be correlated with their clinical phenotypes. In homogenates of mass-cultured I-cells from patients with MLII (I-cell disease), the residual specific activity of beta-galactosidase is between 3 and 5 times lower than that in the I-cells from patients with MLIII (pseudopolydystrophy). This difference is confirmed in several coverslip culture experiments where conditions of inoculation, propagation, harvest and enzyme assays are rigidly controlled. MLIII cells also hydrolyse the natural substrates asialofetuin-(H)3-galactoside and GM1- (H)3-galactoside more easily. This observation offers support to the hypothesis that beta-galactosidase may play a role in the physiopathology of these mucolipidoses.
Similar articles
-
A microassay for acid beta-galactosidase activity toward asialofetuin.Clin Chim Acta. 1985 Nov 15;152(3):307-14. doi: 10.1016/0009-8981(85)90106-8. Clin Chim Acta. 1985. PMID: 2415273
-
The complementation of beta-galactosidase in fused cells of mucolipidosis II with another variants of beta-galactosidase deficiency using new single cell enzyme assay.Biochem Biophys Res Commun. 1979 May 28;88(2):559-62. doi: 10.1016/0006-291x(79)92084-9. Biochem Biophys Res Commun. 1979. PMID: 111672 No abstract available.
-
Beta-galactosidase in tissue culture derived from human skin and bone marrow. Enzyme defect in GM1 gangliosidosis.Pediatr Res. 1969 Nov;3(6):532-7. doi: 10.1203/00006450-196911000-00002. Pediatr Res. 1969. PMID: 5361691 No abstract available.
-
Abnormal lysosomal hydrolases excreted by cultured fibroblasts in I-cell disease (mucolipidosis II).Biochem Biophys Res Commun. 1975 Dec 1;67(3):956-64. doi: 10.1016/0006-291x(75)90768-8. Biochem Biophys Res Commun. 1975. PMID: 1201084 No abstract available.
-
Mucolipidosis type II and type III: a systematic review of 843 published cases.Genet Med. 2021 Nov;23(11):2047-2056. doi: 10.1038/s41436-021-01244-4. Epub 2021 Jun 25. Genet Med. 2021. PMID: 34172897
Cited by
-
A variant of mucolipidosis. II. Clinical, biochemical and pathological investigations.Eur J Pediatr. 1988 Apr;147(3):321-7. doi: 10.1007/BF00442708. Eur J Pediatr. 1988. PMID: 2839346
-
Evidence for the deficiency of beta-glucosidase-activating factor in fibroblasts of patients with I-cell disease.Hum Genet. 1982;62(1):66-9. doi: 10.1007/BF00295605. Hum Genet. 1982. PMID: 6818133
-
Defective catabolism of low-density lipoprotein by fibroblasts from patients with I-cell disease.Biochem J. 1982 Jan 15;202(1):183-90. doi: 10.1042/bj2020183. Biochem J. 1982. PMID: 7082306 Free PMC article.
-
Deficiency of neuraminidase in the sialidoses and the mucolipidoses.Hum Genet. 1980;53(3):383-8. doi: 10.1007/BF00287060. Hum Genet. 1980. PMID: 7372342
-
Temporomandibular joint destruction in mucolipidosis type III necessitating gastrostomy insertion.Eur J Pediatr. 2005 Dec;164(12):772-4. doi: 10.1007/s00431-005-1727-7. Epub 2005 Jul 22. Eur J Pediatr. 2005. PMID: 16041526
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
